Filing Details
- Accession Number:
- 0001127602-13-010618
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-13 12:38:28
- Reporting Period:
- 2013-03-12
- Filing Date:
- 2013-03-13
- Accepted Time:
- 2013-03-13 12:38:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711404 | Cooper Companies Inc | COO | Ophthalmic Goods (3851) | 942657368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1181959 | S Robert Weiss | 6140 Stoneridge Mall Road Suite 590 Pleasanton CA 94588 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-12 | 33,000 | $13.21 | 152,428 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-03-12 | 20,000 | $13.21 | 172,428 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-12 | 47,594 | $105.11 | 124,834 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-12 | 5,406 | $106.07 | 119,428 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2013-03-12 | 33,000 | $0.00 | 33,000 | $13.21 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-03-12 | 20,000 | $0.00 | 20,000 | $13.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-12-09 | No | 4 | M | Direct | |
| 0 | 2009-10-31 | 2018-12-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 0 | Indirect | 401(k) |
Footnotes
- Sale price represents an average of the selling prices between $105.00 and 105.64.
- Sale price represents an average of the selling prices between $106.00 and 106.31.
- 12/10/08 NQ Grant: The options will vest in equal increments over four years measured from the date of grant as follows: 1/4 shall vest on 12/10/09; 1/4 shall vest on 12/10/10; 1/4 shall vest on 12/10/11; and 1/4 shall vest on 12/10/12.
Billionaire Hedge Funds
